Lamb Weston (LW)
(Delayed Data from NYSE)
$78.22 USD
+7.22 (10.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $78.22 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.22 USD
+7.22 (10.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $78.22 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth D Momentum A VGM
Zacks News
Zacks Investment Ideas feature highlights: The Hershey Company, Lamb Weston and Inter Parfums
by Zacks Equity Research
The Hershey Company, Lamb Weston and Inter Parfums are part of the Zacks Investment Ideas article.
3 Stocks Tailored for a Defensive Approach
by Derek Lewis
Negative sentiment has flowed into the market following the crumbling of Silicon Valley Bank, with many financial stocks feeling the drag. With volatility high, should investors consider defensive sectors?
Here's Why Clorox (CLX) is Marching Ahead of Its Industry
by Zacks Equity Research
Despite inflation concerns, Clorox (CLX) looks well poised to drive growth in the future on the back of solid demand, pricing actions, cost savings efforts and other growth strategies.
Philip Morris (PM) Solid Smoke-Free Products Aid Amid High Costs
by Zacks Equity Research
Philip Morris (PM) benefits from its smoke-free products and robust pricing power amid cost inflation.
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RHS)?
by Zacks Equity Research
Sector ETF report for RHS
McCormick (MKC) Down More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
McCormick (MKC) is battling escalated cost inflation and supply-chain expenses, which are denting its gross margin.
United Natural (UNFI) Q2 Earnings Miss Estimates, Sales Rise
by Zacks Equity Research
United Natural's (UNFI) second-quarter fiscal 2023 results reflect lower earnings on inflationary pressure and supply chain volatility. Nevertheless, sales grew year over year.
Campbell (CPB) Beats on Q2 Earnings & Sales, Raises FY23 View
by Zacks Equity Research
Campbell's (CPB) Q2 results reflect higher net sales and earnings on growth across all segments. Management raises the fiscal 2023 view.
Is Hershey (HSY) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Hershey (HSY) and Lamb Weston (LW) have performed compared to their sector so far this year.
Hormel Foods (HRL) Q1 Earnings Miss Estimates, Sales Dip Y/Y
by Zacks Equity Research
Hormel Foods' (HRL) first-quarter earnings and sales decline year over year due to inflationary pressures and supply chain inefficiencies. Management lowers fiscal 2023 earnings outlook.
4 Low-Beta Stocks to Buy to Combat the Volatile Market
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Employers Holdings (EIG), The Hershey (HSY), Lamb Weston (LW) and Novo Nordisk (NVO) are poised to gain.
Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPME
Inter Parfums (IPAR) Q4 Earnings Increase, 2023 View Rises
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter 2022 results reflect higher earnings and sales on growth across Europe and U.S.-based operations. Management raises the 2023 view.
Lamb Weston's (LW) Latest Expansion Effort Accelerates Growth
by Zacks Equity Research
Lamb Weston (LW) acquires remaining equity interests in its European joint venture with Meijer Frozen Foods B.V.
Monster Beverage (MNST) Dips on Q4 Earnings & Sales Miss
by Zacks Equity Research
Monster Beverage's (MNST) Q4 results reflect gains from a strong brand performance, innovation, product launches and pricing actions amid elevated logistic and input costs.
B&G Foods (BGS) Gains Almost 15% on Q4 Earnings & Sales Beat
by Zacks Equity Research
B&G Foods' (BGS) fourth-quarter fiscal 2022 results reflect gains from pricing and a moderating inflationary environment. Both earnings and sales increase year over year.
Best Growth Stocks to Buy for March 1st
by Zacks Equity Research
IFNNY, HSIC and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 1, 2023.
Zacks.com featured highlights Lamb Weston, Catalyst Pharmaceuticals and Northeast Community Bank
by Zacks Equity Research
Lamb Weston, Catalyst Pharmaceuticals and Northeast Community Bank have been highlighted in this Screen of The Week article.
The J.M. Smucker (SJM) Q3 Earnings Beat, Sales Increase Y/Y
by Zacks Equity Research
The J.M. Smucker's (SJM) third-quarter fiscal 2023 results reflect higher sales on positive net price realization. However, earnings decline from the year-ago quarter's reported figure.
3 Top Profitable Stocks to Buy on Solid Net Income Ratio
by Tirthankar Chakraborty
Lamb Weston (LW), Catalyst Pharmaceuticals (CPRX) and Northeast Community Bancorp (NECB) are some of the top picks with a high net income ratio.
Best Growth Stocks to Buy for February 27th
by Zacks Equity Research
ELF, DTEGY and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 27, 2023.
How to Find Strong Buy Consumer Staples Stocks Using the Zacks Rank
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Keurig Dr Pepper (KDP) Q4 Earnings Miss, Sales Beat Estimates
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q4 results gain from the robust performance in its cold beverages, double-digit growth across all four segments and better pricing. KDP issues an upbeat 2023 view.
Best Growth Stocks to Buy for February 23rd
by Zacks Equity Research
HSIC, LW and ELF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 23, 2023.
Medifast (MED) Stock Down Despite Q4 Earnings, Sales Beat
by Zacks Equity Research
Medifast's (MED) fourth-quarter 2022 results reflect reduced Coach productivity and cost inflation. While earnings increase year over year, revenues dip